Leading Neuroblastoma Cells To Die by Multiple Premeditated Attacks from a Multifunctionalized Nanoconstruct

被引:28
作者
Jiao, Peifu [2 ,3 ]
Zhou, Hongyu [3 ]
Otto, Mario [4 ]
Mu, Qingxin [3 ]
Li, Liwen [1 ,3 ]
Su, Gaoxing [1 ,3 ]
Zhang, Yi [2 ,3 ]
Butch, Elizabeth R. [5 ]
Snyder, Scott E. [5 ]
Jiang, Guibin [6 ]
Yan, Bing [1 ,3 ]
机构
[1] Shandong Univ, Sch Chem & Chem Engn, Jinan 250012, Shandong, Peoples R China
[2] Shandong Univ, Sch Pharmaceut Sci, Jinan 250012, Shandong, Peoples R China
[3] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA
[4] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA
[5] St Jude Childrens Res Hosp, Dept Radiol Sci, Memphis, TN 38105 USA
[6] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, Beijing 100085, Peoples R China
基金
中国国家自然科学基金;
关键词
GOLD NANOPARTICLES; ANTI-GD2; ANTIBODY; THERAPY; CANCER; LINES; SENSITIVITY; RESISTANCE; ANTIGEN;
D O I
10.1021/ja206118a
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
To conquer complex and devastating diseases such as cancer, more coordinated and combined attack strategies are needed. We suggest that these can be beautifully achieved by using nanoconstruct design. We present an example showing that neuroblastoma cells are selectively killed by a nanoconstruct that specifically targets neuroblastoma cells, pushes cells to the vulnerable phase of the cell cycle, and greatly enhances radiation-induced cell death. The success of this multipronged attack approach launched by cell-embedded nanoconstructs demonstrates the power and flexibility of nanotechnology in treating cancer, a difficult task for a small molecule.
引用
收藏
页码:13918 / 13921
页数:4
相关论文
共 29 条
[1]   Outcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma. [J].
Baker, David L. ;
Schmidt, Mary L. ;
Cohn, Susan L. ;
Maris, John M. ;
London, Wendy B. ;
Buxton, Allen ;
Stram, Daniel ;
Castleberry, Robert P. ;
Shimada, Hiroyuki ;
Sandler, Anthony ;
Shamberger, Robert C. ;
Look, A. Thomas ;
Reynolds, C. Patrick ;
Seeger, Robert C. ;
Matthay, Katherine K. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (14) :1313-1323
[2]   Design and Characterization of HER-2-Targeted Gold Nanoparticles for Enhanced X-radiation Treatment of Locally Advanced Breast Cancer [J].
Chattopadhyay, Niladri ;
Cai, Zhongli ;
Pignol, Jean-Philippe ;
Keller, Brian ;
Lechtman, Eli ;
Bendayan, Reina ;
Reilly, Raymond M. .
MOLECULAR PHARMACEUTICS, 2010, 7 (06) :2194-2206
[3]  
CHEUNG NKV, 1985, CANCER RES, V45, P2642
[4]   Gold Nanoparticles as Radiation Sensitizers in Cancer Therapy [J].
Chithrani, Devika B. ;
Jelveh, Salomeh ;
Jalali, Farid ;
van Prooijen, Monique ;
Allen, Christine ;
Bristow, Robert G. ;
Hill, Richard P. ;
Jaffray, David A. .
RADIATION RESEARCH, 2010, 173 (06) :719-728
[5]   Radiosensitization of colon cancer cell lines by docetaxel: Mechanisms of action [J].
Dunne, AL ;
Mothersill, C ;
Robson, T ;
Wilson, GD ;
Hirst, DG .
ONCOLOGY RESEARCH, 2004, 14 (09) :447-454
[6]   Multidrug Resistance Through the Spectacle of P-Glycoprotein [J].
Goda, Katalin ;
Bacso, Zsolt ;
Szabo, Gabor .
CURRENT CANCER DRUG TARGETS, 2009, 9 (03) :281-297
[7]  
Goto H, 2003, MOL CANCER THER, V2, P911
[8]   Gold nanoparticles enhance the radiation therapy of a murine squamous cell carcinoma [J].
Hainfeld, James F. ;
Dilmanian, F. Avraham ;
Zhong, Zhong ;
Slatkin, Daniel N. ;
Kalef-Ezra, John A. ;
Smilowitz, Henry M. .
PHYSICS IN MEDICINE AND BIOLOGY, 2010, 55 (11) :3045-3059
[9]  
Hennequin C, 2004, Cancer Radiother, V8 Suppl 1, pS95
[10]   WP744 is a novel anthracycline with enhanced activity against neuroblastoma [J].
Inge, TH ;
Harris, NL ;
Wu, JQ ;
Azizkhan, RG ;
Priebe, W .
JOURNAL OF SURGICAL RESEARCH, 2004, 121 (02) :187-196